The Helix Blog
The Helix Blog gives voice to City of Hope graduate students and their research.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas
August 14, 2019 | Jenny Peters
City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.
First in the nation: City of Hope to offer experimental T cell drug for liver cancer patients
August 5, 2019 | Zen Vuong
An ongoing clinical study in China on the drug showed liver tumor shrinkage, regression of metastatic tumors and fewer side effects than in other T cell clinical trials.
Two new grants aim to advance pancreatic cancer treatment
July 24, 2019 | Cara Martinez
The Pancreatic Cancer Action Network has awarded two City of Hope researchers — Yuan Chen, Ph.D., and Xiaochun Yu, M.D., Ph.D. — $500,000 Translational Research Grants — a total gift of $1 million.
Blood test could predict breast cancer relapse
July 8, 2019 | Zen Vuong
A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.
ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL
June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
Load MoreBack To Top